Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Simonin

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Haematologica|May 19, 2022
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvementCharlotte Rigaud, Samuel Abbou, Stephane Ducassou, et al.
Cancer Epidemiology|September 4, 2020
Maternal exposure to pesticides and risk of childhood lymphoma in France: A pooled analysis of the ESCALE and ESTELLE studies (SFCE)Sandra Mavoungou, Paula Rios, Hélène Pacquement, et al.
Hemasphere|March 23, 2023
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALLMarie Emilie Dourthe, Lucien Courtois, Guillaume P Andrieu, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
Haematologica|March 9, 2023
The oncogenetic landscape and clinical impact of <i>BCL11B</i> alterations in adult and pediatric T-cell acute lymphoblastic leukemiaMarie Emilie Dourthe, Guillaume P Andrieu, Amandine Potier, et al.
Blood Advances|August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at DiagnosisMathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Bulletin Du Cancer|April 16, 2023
[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma]Marie Emilie Dourthe, Mathieu Simonin, Charlotte Rigaud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2022
Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemiaChristophe Bontoux, Mathieu Simonin, Nathalie Garnier, et al.
Nature Communications|March 4, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancerGuillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Haematologica|May 19, 2022
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvementCharlotte Rigaud, Samuel Abbou, Stephane Ducassou, et al.
Cancer Epidemiology|September 4, 2020
Maternal exposure to pesticides and risk of childhood lymphoma in France: A pooled analysis of the ESCALE and ESTELLE studies (SFCE)Sandra Mavoungou, Paula Rios, Hélène Pacquement, et al.
Hemasphere|March 23, 2023
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALLMarie Emilie Dourthe, Lucien Courtois, Guillaume P Andrieu, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
Haematologica|March 9, 2023
The oncogenetic landscape and clinical impact of <i>BCL11B</i> alterations in adult and pediatric T-cell acute lymphoblastic leukemiaMarie Emilie Dourthe, Guillaume P Andrieu, Amandine Potier, et al.
Blood Advances|August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at DiagnosisMathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Bulletin Du Cancer|April 16, 2023
[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma]Marie Emilie Dourthe, Mathieu Simonin, Charlotte Rigaud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2022
Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemiaChristophe Bontoux, Mathieu Simonin, Nathalie Garnier, et al.
Nature Communications|March 4, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancerGuillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, et al.
Pageof 5